Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
198
-
Total 13F shares, excl. options
-
69.3M
-
Shares change
-
+2.33M
-
Total reported value, excl. options
-
$1.65B
-
Value change
-
+$49.4M
-
Put/Call ratio
-
2.04
-
Number of buys
-
118
-
Number of sells
-
-75
-
Price
-
$23.75
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q1 2016
231 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q1 2016.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 198 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69.3M shares
of 115M outstanding shares and own 60.17% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (7.56M shares), VANGUARD GROUP INC (4.86M shares), OAK RIDGE INVESTMENTS LLC (2.8M shares), JANUS CAPITAL MANAGEMENT LLC (2.42M shares), Van Berkom & Associates Inc. (2.14M shares), Bank of New York Mellon Corp (2.11M shares), TimesSquare Capital Management, LLC (1.95M shares), BlackRock Fund Advisors (1.87M shares), Select Equity Group, L.P. (1.86M shares), and BlackRock Institutional Trust Company, N.A. (1.73M shares).
This table shows the top 198 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.